Molecular Mechanisms of Tumor Immunity

Moderator(s)

• 

  David Sanin, PhD (he/him/his)

  Assistant Professor
  Johns Hopkins Univ. Sch. of Med.
  Baltimore, Maryland, United States
• 

  Paul Thomas, PhD (he/him/his)

  Professor
  Fred Hutchinson Cancer Res. Ctr.
  Seattle, Washington, United States

Presentations:

• 12:45 PM - 1:00 PM US ET

  Extracellular cAMP as a potent immune modulator promotes T cell exhaustion in chronic lymphocytic leukemia
  

  Author: Shokrollah Elahi, MD, PhD (he/him/his) – University of Alberta
• 1:00 PM - 1:15 PM US ET

  Identification of a FoxP3-specific small molecule degrader with potent antitumor immunotherapeutic efficacy
  

  Author: Amy Tang – Northwestern University
• 1:15 PM - 1:30 PM US ET

  Immunological targeting of the endogenous retroviral protein ERVMER34-1 in carcinomas promotes epitope spread and enhances response to PD-L1 blockade
  

  Author: Duane H. Hamilton, PhD (he/him/his) – National Cancer Institute, Center for Cancer Research, National Institutes of Health
• 1:30 PM - 1:45 PM US ET

  A universal CD4 epitope enhances cytotoxic T-cell priming and memory in glioblastoma peptide vaccination
  

  Author: Kelly Hotchkiss, PhD – Duke University School of Medicine
• 1:45 PM - 2:00 PM US ET

  Mouse EL4 lymphoma strains differentially respond to a loss of BCATc from T cells and αCTLA4 immunotherapy
  

  Author: Elitsa Ananieva-Stoyanova, PhD (she/her/hers) – Des Moines University
• 2:00 PM - 2:15 PM US ET

  The role of the transcription factor Blimp-1 in T cells in anti-PD1 immunotherapy in non-small cell lung cancer
  

  Author: Susetta Finotto, PhD (she/her/hers) – University Hospital Erlangen